Abstract
Pathology assessment is necessary to make the correct diagnosis of soft tissue tumors. In particular, the correct definition of the tumor type is crucial for both prognostic evaluation and therapeutic management, which can greatly vary based on the histological classification. The WHO classification of soft tissue tumors does not include a number of mesenchymal tumors such as some skin and visceral neoplasms (e.g., kidney soft tissue tumors): in contrast, all soft tissue tumors (independently of their site of origin) are covered in this book.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Readings
Fletcher (2020) WHO classification of tumours of soft tissue and bone, 5th edn
Goldblum (2019) Enzinger & Weiss’s soft tissue tumors, 7th edn
Hornick (2019) Limited biopsies of soft tissue tumors: the contemporary role of immunohistochemistry and molecular diagnostics. Mod Pathol 32(Suppl 1):27–37
Jain (2010) Molecular classification of soft tissue sarcomas and its clinical applications. Int J Clin Exp Pathol 3(4):416–428
Lindberg (2018) Diagnostic pathology: soft tissue tumors, 2nd edn
Miettinen (2006) From morphological to molecular diagnosis of soft tissue tumors. Adv Exp Med Biol 587:99–113
Papke (2019) Practical application of cytology and core biopsy in the diagnosis of mesenchymal tumors. Surg Pathol Clin 12(1):227–248
Schaefer (2018) Diagnostic immunohistochemistry for soft tissue and bone tumors: an update. Adv Anat Pathol 25(6):400–412
Thway (2020) Update on selected advances in the immunohistochemical and molecular genetic analysis of soft tissue tumors. Virchows Arch 476(1):3–15
Wei (2017) Soft tissue tumor immunohistochemistry update: illustrative examples of diagnostic pearls to avoid pitfalls. Arch Pathol Lab Med 141(8):1072–1091
Yao (2020) An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas. Cancer Treat Rev 85:101987
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mocellin, S. (2021). Pathology. In: Soft Tissue Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-58710-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58709-3
Online ISBN: 978-3-030-58710-9
eBook Packages: MedicineMedicine (R0)